MedPath

ARIDOL

ARIDOL

Approved
DIN Number

02489562

Drug Class

Human

Market Date

Jun 15, 2020

Company
HC

PHARMAXIS EUROPE LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02489562
AIG Number0461510001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription Recommended
A
ATC Code
V04CX OTHER DIAGNOSTIC AGENTS
Product Specifications
Dosage FormPowder ,  Kit
Route of AdministrationInhalation
AHFS Classification36:00.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

MANNITOLActive
Strength: 10 MG / CAP
Monograph: MANNITOL
MANNITOLActive
Strength: 40 MG / CAP
Monograph: MANNITOL
MANNITOLActive
Strength: 20 MG / CAP
Monograph: MANNITOL
MANNITOLActive
Strength: 5 MG / CAP
Monograph: MANNITOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.